Enargan, John Ezra Earl C.

HRN: 28-56-80  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/18/2026
02/18/2026
IV
1gm
PTOR
Lacerated Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines